These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 27126975)
21. FTY720 versus mycophenolate mofetil in de novo renal transplantation: six-month results of a double-blind study. Tedesco-Silva H; Szakaly P; Shoker A; Sommerer C; Yoshimura N; Schena FP; Cremer M; Hmissi A; Mayer H; Lang P; Transplantation; 2007 Oct; 84(7):885-92. PubMed ID: 17984842 [TBL] [Abstract][Full Text] [Related]
22. The Consistency and Reporting of Quality-of-Life Outcomes in Trials of Immunosuppressive Agents in Kidney Transplantation: A Systematic Review and Meta-analysis. Howell M; Wong G; Turner RM; Tan HT; Tong A; Craig JC; Howard K Am J Kidney Dis; 2016 May; 67(5):762-74. PubMed ID: 26724168 [TBL] [Abstract][Full Text] [Related]
23. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group. Gruessner RW Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719 [TBL] [Abstract][Full Text] [Related]
24. Sirolimus versus tacrolimus in kidney transplant recipients receiving mycophenolate mofetil and steroids: focus on acute rejection, patient and graft survival. Yang A; Wang B Am J Ther; 2015; 22(2):98-104. PubMed ID: 23921809 [TBL] [Abstract][Full Text] [Related]
26. Basiliximab: a review of its use as induction therapy in renal transplantation. Chapman TM; Keating GM Drugs; 2003; 63(24):2803-35. PubMed ID: 14664658 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of induction therapy with alemtuzumab in kidney transplantation: a meta-analysis. Shou ZF; Zhou Q; Cai JR; Cheng J; He Q; Wu JY; Chen JH Chin Med J (Engl); 2009 Jul; 122(14):1692-8. PubMed ID: 19719973 [TBL] [Abstract][Full Text] [Related]
28. The effectiveness and cost-effectiveness of methods of storing donated kidneys from deceased donors: a systematic review and economic model. Bond M; Pitt M; Akoh J; Moxham T; Hoyle M; Anderson R Health Technol Assess; 2009 Aug; 13(38):iii-iv, xi-xiv, 1-156. PubMed ID: 19674537 [TBL] [Abstract][Full Text] [Related]
29. Induction Therapy, Rejection, and Graft Outcomes in Pediatric and Adolescent Kidney Transplant Recipients. Mincham CM; Wong G; Teixeira-Pinto A; Kennedy S; Alexander S; Larkins N; Lim WH Transplantation; 2017 Sep; 101(9):2146-2151. PubMed ID: 28832451 [TBL] [Abstract][Full Text] [Related]
30. Early Versus Late Acute Antibody-Mediated Rejection Among Renal Transplant Recipients in Terms of Response to Rituximab Therapy: A Single Center Experience. Gheith O; Al-Otaibi T; Halim MA; Mahmoud T; Nair P; Monem MA; Al-Waheeb S; Hassan R; Nampoory N Exp Clin Transplant; 2017 Feb; 15(Suppl 1):150-155. PubMed ID: 28260457 [TBL] [Abstract][Full Text] [Related]
31. Projecting long-term graft and patient survival after transplantation. Levy AR; Briggs AH; Johnston K; MacLean JR; Yuan Y; L'Italien GJ; Kalsekar A; Schnitzler MA Value Health; 2014 Mar; 17(2):254-60. PubMed ID: 24636384 [TBL] [Abstract][Full Text] [Related]
32. Conclusions from the symposium. Campistol JM Transplant Proc; 2010 Nov; 42(9 Suppl):S47-8. PubMed ID: 21095453 [TBL] [Abstract][Full Text] [Related]
33. FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation. Tedesco-Silva H; Mourad G; Kahan BD; Boira JG; Weimar W; Mulgaonkar S; Nashan B; Madsen S; Charpentier B; Pellet P; Vanrenterghem Y Transplantation; 2005 Jun; 79(11):1553-60. PubMed ID: 15940045 [TBL] [Abstract][Full Text] [Related]
34. Immunotherapy for De Novo renal transplantation: what's in the pipeline? Tedesco Silva H; Pinheiro Machado P; Rosso Felipe C; Medina Pestana JO Drugs; 2006; 66(13):1665-84. PubMed ID: 16978033 [TBL] [Abstract][Full Text] [Related]
35. Control of intestinal allograft rejection by FTY720 and costimulation blockade. Yan S; Rodriguez-Barbosa JI; Pabst O; Beckmann JH; Brinkmann V; Förster R; Hoffmann MW Transplant Proc; 2005; 37(1):114-5. PubMed ID: 15808565 [TBL] [Abstract][Full Text] [Related]
36. Systematic Review on Role of Mammalian Target of Rapamycin Inhibitors as an Alternative to Calcineurin Inhibitors in Renal Transplant: Challenges and Window to Excel. Kumar J; Bridson JM; Sharma A; Halawa A Exp Clin Transplant; 2017 Jun; 15(3):241-252. PubMed ID: 27915965 [TBL] [Abstract][Full Text] [Related]
37. Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data. Knoll GA; Kokolo MB; Mallick R; Beck A; Buenaventura CD; Ducharme R; Barsoum R; Bernasconi C; Blydt-Hansen TD; Ekberg H; Felipe CR; Firth J; Gallon L; Gelens M; Glotz D; Gossmann J; Guba M; Morsy AA; Salgo R; Scheuermann EH; Tedesco-Silva H; Vitko S; Watson C; Fergusson DA BMJ; 2014 Nov; 349():g6679. PubMed ID: 25422259 [TBL] [Abstract][Full Text] [Related]